INVO Fertility (IVF) Cash & Current Investments (2010 - 2026)
INVO Fertility's (IVF) quarterly Cash & Current Investments came in at $4.9 million in Q1 2026, up 483.58% year-on-year from $840407.0 in Q1 2025, and up 136.04% on a QoQ basis from $2.1 million in Q4 2025.
INVO Fertility (IVF) Cash & Current Investments (2010 - 2026) Analysis & Trends
INVO Fertility (IVF) has 17 years of Cash & Current Investments data on file, last reported at $4.9 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 483.58% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 483.58% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 180.26% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $4.9 million, up from $2.1 million in the prior quarter.
- Over the last five years, Cash & Current Investments for IVF reached as high as $4.9 million in Q1 2026 and fell as low as $90135.0 in Q4 2022.
- Historically, Cash & Current Investments has averaged $1.3 million across 5 years, with a median of $840407.0 in 2025.
- Across the five-year window, Cash & Current Investments sank 98.41% in 2022 and jumped 738.28% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $90135.0 in 2022, then soared by 157.86% to $232424.0 in 2023, then soared by 218.98% to $741396.0 in 2024, then surged by 180.26% to $2.1 million in 2025, then jumped by 136.04% to $4.9 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $4.9 million in Q1 2026, $2.1 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 1.12 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 3.12 Bn |
| 10 | INVO Fertility | 1.57 Mn | -3.33 Mn | 732,978.00 | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 549,181.00 |
| Mar 31, 2025 | 840,407.00 |
| Dec 31, 2024 | 741,396.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 942,934.00 |
| Mar 31, 2024 | 475,125.00 |
| Dec 31, 2023 | 232,424.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 112,485.00 |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 90,135.00 |
| Sep 30, 2022 | 285,697.00 |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 3.84 Mn |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 6.64 Mn |